Severe invasive group a streptococcal infections: A subject review

Pediatrics

Volumn 101, Issue 1 I, 1998, Pages 136-140

  Halsey, N A ^a   Abramson, J S ^a   Chesney, P J ^a   Fisher, M C ^a   Gerber, M A ^a   Gromisch, D S ^a   Kohl, S ^a   Marcy, S M ^a   Murray, D L ^a   Overturf, G D ^a   Whitley, R J ^a   Yogev, R ^a   Peter, G ^a   Hall, C B ^a   Schwartz, B ^a   Breiman, R ^a   Hardegree, M C ^a   Jacobs, R F ^a   MacDonald, N E ^a   Orenstein, W A ^a   Rabinovich, N R ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; RIFAMPICIN;

ANTIBIOTIC THERAPY; CHEMOPROPHYLAXIS; CHICKENPOX; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NECROTIZING FASCIITIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; SURGICAL DRAINAGE;

EID: 0031975985     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.1.136     Document Type: Review

References (32)

1. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1-7
2. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA. 1993;269: 384-389
3. Wheeler MC, Roe MH, Kaplan EL, Schlievert PM, Todd JK. Outbreak of group A streptococcus septicemia in children: clinical, epidemiologic, and microbiological correlates. JAMA. 1991;266:533-537
4. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis. 1995;1: 69-78
5. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. JAMA. 1993;269:390-391
6. Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clin Infect Dis. 1992;14:298-307
7. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis. 1992;14:2-11
8. Schlievert PM, Assimacopoulos AP, Cleary PP. Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med. 1996;127:13-22
9. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med. 1996;335:547-554
10. Centers for Disease Control and Prevention. Group A beta-hemolytic streptococcal bacteremia: Colorado, 1989. MMWR. 1990;39:3-6
11. O'Brien KL, Levine OS, Schwartz B. The changing epidemiology of group A streptococcus infections. Semin Pediatr Infect Dis. 1997;8:1-8
12. Davies HD, Matlow A, Scriver SR, et al. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J. 1994;13:49-56
13. Demers B, Simor AE, Vellend H, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis. 1993; 16:792-800
14. Centers for Disease Control and Prevention. Outbreak of invasive group A Streptococcus associated with varicella in a childcare center - Boston, Massachusetts, 1997. MMWR. 1997;46:994-948
15. Schwartz B, Elliott JA, Butler JC, et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis. 1992;15:277-284
16. DiPersio JR, File TM Jr, Stevens DL, Gardner WG, Petropoulos G, Dinsa K. Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. Clin Infect Dis. 1996;22:490-495
17. Wilson GJ, Talkington DF, Gruber W, Edwards K, Dermody TS. Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. Clin Infect Dis. 1995;20:1333-1338
18. Brogan TV, Nizet V, Waldhausen JH, Rubens CE, Clarke WR. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J. 1995;14:588-594
19. Doctor A, Harper MB, Fleisher GR. Group A beta-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics. 1995;96:428-433
20. Rimailho A, Riou B, Richard C, Auzepy P. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis. 1987:155: 143-146
21. Stevens DL. Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 1995;21:977-980
22. Zittergruen M, Grose C. Magnetic resonance imaging for early diagnosis of necrotizing fasciitis. Pediatr Emerg Care. 1993;9:26-28
23. Gerber MA. Antibiotic resistance in group A streptococci. Pediatr Clin North Am. 1995;42:539-551
24. Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988;158:23-28
25. Cornaglia G, Ligozzi M, Mazzariol A, Valentini M, Orefici G, Fontana R. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-95. Emerg Infect Dis. 1996;2:339-342
26. Lamothe F, D'Amico P, Ghosn P, Tremblay C, Braidy J, Patenaude JV. Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: case report and review. Clin Infect Dis. 1995;21:1469-1470
27. Barry W, Hudgins L, Donta ST, Pesanti EL. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA. 1992;267:3315-3316
28. Low DE. Treatment of severe invasive disease. Program and abstracts of 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1996; New Orleans, LA. Abstract 8103
29. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med. 1996;334:1642-1648
30. Tanz RR, Shulman ST, Barthel MJ, et al. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr. 1985;106: 876-880
31. Tanz RR, Poncher JR, Corydon KE, et al. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr. 1991;119: 123-128
32. Davies HD, Low DE, Schwartz B, et al. Evaluation of short-course therapy with cefixime or rifampin for eradication of pharyngeally carried group A streptococci. Clin Infect Dis. 1995;21:1294-1299